Medication info
Clopidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Clopidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Bukhoong Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30, 300 tablets/bottle
Approval status
Active

MFDS item code 200503302 · Approved 2005.10.26 · Insurance code 642203410

Summary

Main use
Improvement of symptoms of atherosclerosis (including myocardial infarction); prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), begin treatment on the day this medicine is initiated with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
Bukhoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis (including myocardial infarction); prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-ST segment elevation myocardial infarction
  • cardiovascular issues
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms caused by atherosclerosis in adult patients with vascular issues such as ischemic stroke, myocardial infarction, and peripheral artery disease. It also helps reduce the risk of death due to cardiovascular issues, stroke, and myocardial infarction in patients with acute coronary syndrome, particularly those with unstable angina or non-ST segment elevation myocardial infarction, who have undergone coronary intervention or coronary artery bypass surgery. This drug also decreases the risk of stroke and thrombosis in patients with atrial fibrillation who have one or more vascular risk factors, especially when vitamin K antagonists cannot be used or in cases of low bleeding risk. In summary, this medication effectively improves the symptoms associated with atherosclerosis and thrombosis in various vascular-related disorders and assists in reducing risk.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), begin treatment on the day this medicine is initiated with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This drug acts as an active metabolite to prevent platelets from aggregating, thereby preventing thrombus formation. Patients with genetically reduced function of a specific enzyme (CYP2C19) may experience decreased efficacy of this drug; in such cases, treatment adjustments should be made. Co-administration with drugs that activate this enzyme may increase drug levels and elevate the risk of bleeding, so co-administration should be avoided. This drug should not be given to patients with a known allergy to this drug or its components, those with bleeding issues, severe liver impairment, nursing women, or patients with certain genetic lactose intolerance. Patients with a high risk of bleeding, impaired liver or kidney function, recent stroke, hypertension, the elderly, etc., should use this medication with caution, and it may be necessary to stop administration before surgery after consulting with a physician. This drug may prolong bleeding time and increase the risk of bleeding; thus, patients should inform their doctor immediately if any bleeding symptoms occur. Care should be taken when co-administering with other bleeding risk medications, anticoagulants, antiplatelet agents, and some antidepressants. During pregnancy, the risk of bleeding may increase; thus, use should be determined at the physician's discretion, and if breastfeeding, a decision must be made regarding whether to discontinue nursing due to the possibility of drug excretion into breast milk. Safety in children has not been established, and the elderly may experience adverse reactions such as bleeding due to declining body function and should be monitored closely. Overdose may increase the risk of bleeding; if necessary, platelet transfusions can reverse the effects. While taking this medication, patients should be aware of potential adverse reactions such as bleeding symptoms, rash, headache, dyspepsia, etc., and consult healthcare professionals if any symptoms arise. Additionally, this medication should be kept out of reach of children and should not be transferred into other containers for safety.

Side effects

  • Hemorrhage
  • gastrointestinal hemorrhage
  • hemorrhage requiring hospitalization
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
Show 126 more
  • intracranial hemorrhage
  • significant hemorrhage
  • minor hemorrhage
  • hemorrhagic stroke
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • abdominal pain
  • indigestion
  • diarrhea
  • nausea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • fainting
  • palpitations
  • asthenia
  • fever
  • hernia
  • heart failure
  • atrial fibrillation
  • leg cramps
  • sensory neuropathy
  • neuralgia
  • sensory disturbance
  • vertigo
  • constipation
  • vomiting
  • increased liver enzymes
  • gout
  • hyperuricemia
  • arthralgia
  • low back pain
  • anxiety
  • insomnia
  • anemia
  • bloody stools
  • cerebral hemorrhage
  • gingival bleeding
  • pneumonia
  • sinusitis
  • eczema
  • skin ulcer
  • cystitis
  • cataract
  • conjunctivitis
  • reduced motor function
  • tremor
  • voice disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • perceptual disturbances
  • insomnia
  • depression
  • forgetfulness
  • anxiety
  • hypomania
  • abnormal experiences
  • abnormal behavior
  • weight loss
  • weight gain
  • facial flushing
  • rigidity
  • facial edema
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • maculopapular rash
  • erythematous skin rash
  • urticaria
  • itching
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • arthritis
  • myalgia
  • glomerular disease
  • gynecomastia
  • fever
  • abnormal liver function tests
  • increased blood creatinine
  • allergic symptoms
  • ischemic necrosis
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal hemorrhage
  • pulmonary hemorrhage
  • thrombocytopenia
  • hypochromic anemia
  • leukemia
  • leukopenia
  • eosinophilia
  • menorrhagia
  • hemothorax
  • varicella
  • renal dysfunction
  • acute renal failure
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in an airtight container to protect it from air and moisture and kept at room temperature between 1°C and 30°C. Storing it this way will maintain its effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.